Article
The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.
Thrombosis research - 1 Aug 2013
Joachim Emily, Goldenberg Neil A, Bernard Timothy J, Armstrong-Wells Jennifer, Stabler Sally, Manco-Johnson Marilyn J
Abstract excerpt
OBJECTIVE: Elevated plasma homocysteine (tHcy) and the MTHFR c.677C>T variant have been postulated to increase the risk of venous thromboembolism (VTE), although mechanisms and implications to pediatrics remain incompletely understood. The objectives of this study were to determine the prevalences of elevated tHcy and MTHFR variant in a pediatric population with VTE or arterial ischemic stroke (AIS), and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
